Exact Mass: 363.161654
Exact Mass Matches: 363.161654
Found 500 metabolites which its exact mass value is equals to given mass value 363.161654,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Dioncophylline C
C23H25NO3 (363.18343400000003)
An isoquinoline alkaloid that is the biaryl resulting from substitution of the hydrogen at the 5-position of (1R,3R)-1,3-dimethyl-1,2,3,4-tetrahydroisoquinolin-8-ol by a 5-hydroxy-4-methoxy-2-methylnaphthalen-1-yl group. It is a naphthylisoquinoline alkaloid isolated from the roots and stem barks of Triphyophyllum peltatum and exhibits antimalarial activity.
9-Aminocamptothecin
9-Aminocamptothecin (9-Amino-CPT) is a topoisomerase I inhibitor with potent anticancer activity 9-Aminocamptothecin. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=91421-43-1 (retrieved 2024-08-08) (CAS RN: 91421-43-1). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).
Methixene hydrochloride
C20H26ClNOS (363.1423536000001)
C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent
8-Methyldihydrochelerythrine
C22H21NO4 (363.14705060000006)
8-Methyldihydrochelerythrine is found in fruits. 8-Methyldihydrochelerythrine is an alkaloid from root bark of Zanthoxylum simulans (Szechuan pepper). Alkaloid from root bark of Zanthoxylum simulans (Szechuan pepper). 8-Methyldihydrochelerythrine is found in herbs and spices and fruits.
(4-(2-((2-(3-Chlorophenyl)-2-hydroxyethyl)amino)propyl)phenoxy)acetic acid
C19H22ClNO4 (363.1237282000001)
D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists
4-[[5-Chloro-4-(2,4,6-trimethylanilino)pyrimidin-2-yl]amino]benzonitrile
2-(1-(5-Fluoropentyl)-1H-indazole-3-ylcarbonylamino)-3-methylbutanoic acid methyl ester
9-Aminocamptothecin
N-Biotinyl-4-aminobenzoic acid
C17H21N3O4S (363.1252706000001)
Biotinyl-p-aminobenzoate
C17H21N3O4S (363.1252706000001)
Bucindolol
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents Bucindolol is a β1-adrenergic receptor blocker, with intrinsic sympathomimetic activity, used in the research of heart failure[1].
(2S)-1-[(2S)-3-(4H-Imidazol-4-yl)-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]propanoyl]pyrrolidine-2-carboxylic acid
C16H21N5O5 (363.15426160000004)
Dioncophylline C
C23H25NO3 (363.18343400000003)
N-((Tetrahydro-5-oxo-2-furanyl)carbonyl)-L-histidyl-L-prolinamide
C16H21N5O5 (363.15426160000004)
Libenzapril
2-[[[4-(3-Benzylcyclobutyl)-1,3-thiazol-2-yl]diazenyl]methyl]phenol
C21H21N3OS (363.14052560000005)
Pglu-his-pro
C16H21N5O5 (363.15426160000004)
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones Thyrotropin-Releasing Hormone (TRH), Free Acid (TRH-OH) is a physiological metabolite of Thyrotropin-Releasing Hormone.
Thiencynonate
9-Aminocamptothecin
9-Aminocamptothecin is a pyranoindolizinoquinoline. Aminocamptothecin has been used in trials studying the treatment of Lymphoma, Gastric Cancer, Ovarian Cancer, Esophageal Cancer, and Ovarian Neoplasms, among others. Aminocamptothecin is a water-insoluble camptothecin derivative. Aminocamptothecin binds to the nuclear enzyme topoisomerase I, thereby inhibiting repair of single-strand DNA breakages. Because the terminal lactone ring of aminocamptothecin required for the agents antitumor activity spontaneously opens under physiological conditions to an inactive carboxy form, the drug must be administered over an extended period of time to achieve effective cytotoxicity. (NCI04) C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor D000970 - Antineoplastic Agents 9-Aminocamptothecin (9-Amino-CPT) is a topoisomerase I inhibitor with potent anticancer activity[1]. 9-Aminocamptothecin. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=91421-43-1 (retrieved 2024-10-18) (CAS RN: 91421-43-1). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).
antofine
C23H25NO3 (363.18343400000003)
(-)-antofine is an organic heteropentacyclic compound that is (13aR)-9,11,12,13,13a,14-hexahydrodibenzo[f,h]pyrrolo[1,2-b]isoquinoline substituted at positions 2, 3 and 6 by methoxy groups. It is an alkaloid produced by relatives of the milkweed family and exhibits antiviral, anti-inflammatory, antiadipogenic and antitumorigenic activities. It has a role as an antineoplastic agent, a plant metabolite, a phytotoxin, an antimicrobial agent, an anti-inflammatory agent, an antiviral agent and an angiogenesis inhibitor. It is an organic heteropentacyclic compound, an aromatic ether, an alkaloid and an alkaloid antibiotic. (13aR)-2,3,6-trimethoxy-9,11,12,13,13a,14-hexahydrophenanthro[9,10-f]indolizine is a natural product found in Ficus septica, Vincetoxicum paniculatum, and other organisms with data available. An organic heteropentacyclic compound that is (13aR)-9,11,12,13,13a,14-hexahydrodibenzo[f,h]pyrrolo[1,2-b]isoquinoline substituted at positions 2, 3 and 6 by methoxy groups. It is an alkaloid produced by relatives of the milkweed family and exhibits antiviral, anti-inflammatory, antiadipogenic and antitumorigenic activities.
(+)-16-Hydroxy-9-O-demethylgalwesine
C18H21NO7 (363.13179560000003)
N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-benzyl-1H-indole-3-carboxamide
1,3-dihydroxy-2,4-bis(3-methylbut-2-enyl)-9a,10-dihydro-4aH-acridin-9-one|1,3-dihydroxy-2,4-diprenylacridone|atalaphylline
C23H25NO3 (363.18343400000003)
2-[6-(1,3-Benzodioxole-5-yl)hexyl]-4-methoxyquinoline
C23H25NO3 (363.18343400000003)
(15E)-12beta-acetoxy-18-nor-senecionane-11,16-dione|Crotastriatin|crotastriatine|O-acetyl-nilgirine
3,7-dimethoxy-6-hydroxy-11,12,13,14,14a,15-hexahydro-9H-phenanthro[9,10-b]quinolizidine|Boehmeriasin B
C23H25NO3 (363.18343400000003)
glioperazine B
C17H21N3O4S (363.1252706000001)
A member of the class of 2,5-diketopiperazines with an indole substituent. It is a microbial metabolite isolated from the mycelia of a liquid fermentation culture of the fungus, Bionectria byssicola and has been shown to exhibit antibacterial activity against Staphylococcus aureus.
(R)-2-(6-O-trans-2-butenoyl-beta-D-glucopyranosyloxy)-phenylacetonitrile
C18H21NO7 (363.13179560000003)
CAY10581
C22H21NO4 (363.14705060000006)
Naloxone HCl
C19H22ClNO4 (363.1237282000001)
D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D009292 - Narcotic Antagonists C78272 - Agent Affecting Nervous System > C681 - Opiate Antagonist Naloxone hydrochloride is an antagonist of Opioid receptor. Naloxone hydrochloride alleviates opioid-overdose-induced respiratory depression. Naloxone hydrochloride may cause pulmonary edema and cardiac arrhythmias[1].
C21H21N3O3_8,8-Dimethyl-5a,6-dihydro-3H,5H,8H-spiro[indole-2,7-pyrrolo[1,2:4,5]pyrazino[1,2-a]azepine]-3,5,12(1H,2H)-trione
Ala Cys Gly Asn
C12H21N5O6S (363.12124860000006)
Ala Cys Asn Gly
C12H21N5O6S (363.12124860000006)
Ala Gly Cys Asn
C12H21N5O6S (363.12124860000006)
Ala Gly Asn Cys
C12H21N5O6S (363.12124860000006)
Ala Asn Cys Gly
C12H21N5O6S (363.12124860000006)
Ala Asn Gly Cys
C12H21N5O6S (363.12124860000006)
Cys Ala Gly Asn
C12H21N5O6S (363.12124860000006)
Cys Ala Asn Gly
C12H21N5O6S (363.12124860000006)
Cys Gly Ala Asn
C12H21N5O6S (363.12124860000006)
Cys Gly Gly Lys
C13H25N5O5S (363.15763200000004)
Cys Gly Gly Gln
C12H21N5O6S (363.12124860000006)
Cys Gly Lys Gly
C13H25N5O5S (363.15763200000004)
Cys Gly Asn Ala
C12H21N5O6S (363.12124860000006)
Cys Gly Gln Gly
C12H21N5O6S (363.12124860000006)
Cys Lys Gly Gly
C13H25N5O5S (363.15763200000004)
Cys Asn Ala Gly
C12H21N5O6S (363.12124860000006)
Cys Asn Gly Ala
C12H21N5O6S (363.12124860000006)
Cys Gln Gly Gly
C12H21N5O6S (363.12124860000006)
Gly Ala Cys Asn
C12H21N5O6S (363.12124860000006)
Gly Ala Asn Cys
C12H21N5O6S (363.12124860000006)
Gly Cys Ala Asn
C12H21N5O6S (363.12124860000006)
Gly Cys Gly Lys
C13H25N5O5S (363.15763200000004)
Gly Cys Gly Gln
C12H21N5O6S (363.12124860000006)
Gly Cys Lys Gly
C13H25N5O5S (363.15763200000004)
Gly Cys Asn Ala
C12H21N5O6S (363.12124860000006)
Gly Cys Gln Gly
C12H21N5O6S (363.12124860000006)
Gly Gly Cys Lys
C13H25N5O5S (363.15763200000004)
Gly Gly Cys Gln
C12H21N5O6S (363.12124860000006)
Gly Gly Lys Cys
C13H25N5O5S (363.15763200000004)
Gly Gly Gln Cys
C12H21N5O6S (363.12124860000006)
Gly Lys Cys Gly
C13H25N5O5S (363.15763200000004)
Gly Lys Gly Cys
C13H25N5O5S (363.15763200000004)
Gly Asn Ala Cys
C12H21N5O6S (363.12124860000006)
Gly Asn Cys Ala
C12H21N5O6S (363.12124860000006)
Gly Asn Ser Ser
Gly Gln Cys Gly
C12H21N5O6S (363.12124860000006)
Gly Gln Gly Cys
C12H21N5O6S (363.12124860000006)
Gly Ser Asn Ser
Gly Ser Ser Asn
Lys Cys Gly Gly
C13H25N5O5S (363.15763200000004)
Lys Gly Cys Gly
C13H25N5O5S (363.15763200000004)
Lys Gly Gly Cys
C13H25N5O5S (363.15763200000004)
Asn Ala Cys Gly
C12H21N5O6S (363.12124860000006)
Asn Ala Gly Cys
C12H21N5O6S (363.12124860000006)
Asn Gly Ser Ser
Asn Ser Gly Ser
Asn Ser Ser Gly
Ser Gly Asn Ser
Ser Gly Ser Asn
Ser Asn Gly Ser
Ser Asn Ser Gly
Ser Ser Gly Asn
Ser Ser Asn Gly
GSK264220A
C17H21N3O4S (363.1252706000001)
8-Methyldihydrochelerythrine
C22H21NO4 (363.14705060000006)
Serabelisib
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2152 - Phosphatidylinositide 3-Kinase Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor D004791 - Enzyme Inhibitors
Ethyl 5-amino-2-methyl-4-phenyl-1,4,6,7,8,9-hexahydrobenzo[b][1,8 ]naphthyridine-3-carboxylate
AMINO-(3,4-DIBENZYLOXY-PHENYL)-ACETIC ACID
C22H21NO4 (363.14705060000006)
2-(METHYLSULFANYL)[1,3]OXAZOLO[4,5-B]PYRIDINE
C22H21NO4 (363.14705060000006)
dimethyl-bis(prop-2-enyl)azanium,2-hydroxypropyl prop-2-enoate,prop-2-enoic acid,chloride
C17H30ClNO5 (363.18124000000006)
1-FMOC-4-CARBOXYMETHYLENE-PIPERIDINE
C22H21NO4 (363.14705060000006)
B-Paba
C17H21N3O4S (363.1252706000001)
6-(4-(4-CYANOPHENYL)PHENOXY)HEXYL METHA&
C23H25NO3 (363.18343400000003)
3-HYDROXY-2,3-DIMETHYLBUTAN-2-YL HYDROGEN (3-((1,3-DIOXOISOINDOLIN-2-YL)METHYL)PHENYL)BORONATE
C21H22BNO4 (363.16418020000003)
benzyl 2-amino-5-methoxy-4-phenylmethoxybenzoate
C22H21NO4 (363.14705060000006)
benzyl N-[6-oxo-1-(2-oxoethyl)-2-phenylpyrimidin-5-yl]carbamate
(2-PHTALIMIDOMETHYLPHENYL)BORONIC ACID, PINACOL ESTER
C21H22BNO4 (363.16418020000003)
Urea, N-[2-[(3-cyano-8-methyl-2-quinolinyl)amino]ethyl]-N-(4-fluorophenyl)- (9CI)
C20H18FN5O (363.14953099999997)
Urea, N-[2-[(3-cyano-8-methyl-2-quinolinyl)amino]ethyl]-N-(2-fluorophenyl)- (9CI)
C20H18FN5O (363.14953099999997)
4-(4-BENZYLPIPERAZINO)-1H-INDOLE DIHYDROCHLORIDE MONOHYDRATE
[2-(dimethylamino)-2-methylpropyl] 2-hydroxy-2,2-diphenylacetate,hydrochloride
C20H26ClNO3 (363.16011160000005)
(4-PHTHALIMIDOMETHYLPHENYL)BORONIC ACID, PINACOL ESTER
C21H22BNO4 (363.16418020000003)
[4-(Carbazol-9-yl)-1,1-biphenyl-4-yl]boronic acid
C24H18BNO2 (363.14305179999997)
8-Amino-4-ethyl-4-hydroxy-1H-pyrano[3,4:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
(6,9-Diphenyl-9H-carbazol-3-yl)boronic acid
C24H18BNO2 (363.14305179999997)
Efaproxiral sodium
C20H22NNaO4 (363.14464520000007)
C274 - Antineoplastic Agent > C798 - Radiosensitizing Agent
Dibenzyl L-glutamate hydrochloride
C19H22ClNO4 (363.1237282000001)
3-{5-[(2R)-2-Aminopropyl]-7-cyano-2,3-dihydro-1H-indol-1-yl}propy l benzoate
erythro-N-[(Phenylmethoxy)carbonyl]-3-allyl-L-aspartic acid 1-tert-butyl ester
n-methoxy-n-methyl(triphenyl-phosphoranylidene)acetamide
Tris(methylethylketoxime)phenylsilane
C18H29N3O3Si (363.19780840000004)
1-[2-(4-(Trifluoromethyl)phenyl)ethyl]-6,7-dimethoxy-3,4-dihydroisoquinoline
C20H20F3NO2 (363.14460560000003)
1,2,3,4-Tetrahydro-6,7-dimethoxy-3-isoquinolinecarboxylic acid phenylmethyl ester hydrochloride
C19H22ClNO4 (363.1237282000001)
Libenzapril
D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents
Ozenoxacin
D - Dermatologicals > D06 - Antibiotics and chemotherapeutics for dermatological use > D06A - Antibiotics for topical use C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D004791 - Enzyme Inhibitors
(4-(N-ISOPROPYL-N-(4-METHOXYBENZYL)SULFAMOYL)PHENYL)BORONIC ACID
C17H22BNO5S (363.13116720000005)
Thiphenamil hydrochloride
C20H26ClNOS (363.1423536000001)
C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent
antazoline
C17H22N3O4P (363.13478620000006)
D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist D018926 - Anti-Allergic Agents
7-Amino-6-phenoxy-3-[(tetrahydrofuran-2-yl)methyl]quinazolin-4(3H)-one
9-(Biphenyl-4-yl)carbazole-2-boronic acid
C24H18BNO2 (363.14305179999997)
4-(tert-Butyldiphenylsilyloxy)cyclohexanecarbonitrile
5-(2-Aminopropyl)-1-[3-(benzoyloxy)propyl]-2,3-dihydro-1H-indole-7-carbonitrile
GLY-PRO 4-METHOXY-BETA-NAPHTHYLAMIDE HYDROCHLORIDE
4-[(5,6-DIHYDRO[2,3-BIPYRIDIN]-3(4H)-YLIDENE)METHYL]-N,N-DIMETHYLBENZENAMINE DIHYDROCHLORIDE
(3-(N-Isopropyl-N-(4-methoxybenzyl)sulfamoyl)phenyl)boronic acid
C17H22BNO5S (363.13116720000005)
4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1-tosyl-1,2,3,6-tetrahydropyridine
C18H26BNO4S (363.1675506000001)
l-d-(a-Aminoadipoyl)-l-cysteinyl-d-valine
C14H25N3O6S (363.14639900000003)
N-((1-(5-Fluoropentyl)-1H-indazol-3-yl)carbonyl)valine methyl ester
2-(4-((2R)-2-(((2R)-2-(3-Chlorophenyl)-2-hydroxyethyl)amino)propyl)phenoxy)acetic acid
C19H22ClNO4 (363.1237282000001)
D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists
Dioncophylline B
C23H25NO3 (363.18343400000003)
A natural product found in Triphyophyllum peltatum.
2-[4-(1-adamantyl)-N-methylsulfonylanilino]acetic acid
C19H25NO4S (363.15042100000005)
Protuboxepin B
An organic heterotricyclic compound that is 10,11-dihydro-6H-oxepino[2,3-d]pyrazino[1,2-a]pyrimidine-6,9(8H)-dione substituted by a benzyl group at position 8 and an isopropyl group at position 11. It has been isolated from Aspergillus species.
3-(1-azepanylsulfonyl)-N-(3-isoxazolyl)-4-methylbenzamide
C17H21N3O4S (363.1252706000001)
2-[(4-amino-5-cyclohexyl-1,2,4-triazol-3-yl)thio]-N-(3-fluoro-4-methylphenyl)acetamide
D-Galactitol, 2-(acetylmethylamino)-2-deoxy-3,4,6-tri-O-methyl-, 1,5-diacetate
{4-[(2R)-pyrrolidin-2-ylmethoxy]phenyl}(4-thiophen-3-ylphenyl)methanone
C22H21NO2S (363.12929260000004)
19-(Cyclopropylamino)-4,6,7,15-Tetrahydro-5h-16,1-(Azenometheno)-10,14-(Metheno)pyrazolo[4,3-O][1,3,9]triazacyclohexadecin-8(9h)-One
(5E,7S)-2-amino-7-(4-fluoro-2-pyridin-3-ylphenyl)-4-methyl-7,8-dihydroquinazolin-5(6H)-one oxime
C20H18FN5O (363.14953099999997)
(2S)-1-[(2S)-3-(4H-Imidazol-4-yl)-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]propanoyl]pyrrolidine-2-carboxylic acid
C16H21N5O5 (363.15426160000004)
3-[[(E)-4-Methoxy-4-oxo-2-butenoyl]amino]-L-Ala-L-Phe-OH
C17H21N3O6 (363.14302860000004)
(1R,2R,5S,8S,9S,10R,11R,12R,13S)-5,12,13-trihydroxy-11-methyl-6-methylidene-16-oxo-15-oxapentacyclo[9.3.2.15,8.01,10.02,8]heptadecane-9-carboxylate
N-acetyl-alpha-D-muramoyl-L-alaninate
C14H23N2O9- (363.14034879999997)
The carbohydrate acid derivative anion formed by loss of a proton from the carboxy group of N-acetyl-alpha-D-muramoyl-L-alanine; principal microspecies at pH 7.3.
3-{[(2E)-4-methoxy-4-oxobut-2-enoyl]amino}alanyl-L-phenylalanine
C17H21N3O6 (363.14302860000004)
5-(2-Oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl)pentanoyl 4-aminobenzoate
C17H21N3O4S (363.1252706000001)
5-[6-(Cyclohexylamino)-9-purinyl]-2-(hydroxymethyl)-4-methoxy-3-oxolanol
6-(1,3-benzodioxol-5-yl)-N-(3-oxanylmethyl)-4-quinazolinamine
2-[4-(2-methylpropyl)phenyl]propanoic acid [2-(1H-indol-3-yl)-2-oxoethyl] ester
C23H25NO3 (363.18343400000003)
(9S,11R)-12,12-dimethylspiro[1,7-diazatricyclo[7.5.0.03,7]tetradeca-3,13-diene-11,2-1H-indole]-2,3,8-trione
N-ethyl-N-(2-ethylphenyl)-3-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]propanamide
phe-FMDP
C17H21N3O6 (363.14302860000004)
A dipeptide composed of 3-{[(2E)-4-methoxy-4-oxobut-2-enoyl]amino}alanine and L-phenylalanine joined by peptide linkages.
N-(6-acetyl-1,3-benzodioxol-5-yl)-5-methyl-2-phenyl-3-pyrazolecarboxamide
2,4,5-trimethoxy-N-(2-phenylphenyl)benzamide
C22H21NO4 (363.14705060000006)
1H-indazole-3-carboxylic acid 4-(1,3-dioxo-2-isoindolyl)butyl ester
2-[[2-[1-(2-methoxyethyl)-2,5-dimethyl-3-pyrrolyl]-2-oxoethyl]thio]-6-propyl-1H-pyrimidin-4-one
4-[3-(1,3-Dioxo-2-isoindolyl)propylamino]-2-methylisoindole-1,3-dione
1-(4-Fluorophenyl)-1-cyclopentanecarboxylic acid [2-(2,6-dimethyl-4-morpholinyl)-2-oxoethyl] ester
C20H26FNO4 (363.18457680000006)
2-[(1-Amino-1-oxopropan-2-yl)thio]-3-butyl-4-oxo-7-quinazolinecarboxylic acid methyl ester
C17H21N3O4S (363.1252706000001)
5-[(3-Phenylmethoxy-1-piperidinyl)methyl]-3-(phenylmethyl)-1,2,4-oxadiazole
1-(1,3-benzoxazol-2-yl)-N-[(4-ethylphenyl)methyl]-3-piperidinecarboxamide
(5Z)-4-methoxy-3-methyl-5-[(1R,9R,10R,11R,12S)-12-methyl-5-oxido-14,15-dioxa-5-azoniatetracyclo[7.5.1.01,11.05,10]pentadecan-13-ylidene]furan-2-one
1-(4,6-dimethoxy-1,3,5-triazin-2-yl)-N-(thiophen-2-ylmethyl)-4-piperidinecarboxamide
C16H21N5O3S (363.1365036000001)
3-[[4-[(4-chlorophenyl)methyl]-4-(hydroxymethyl)-1-piperidinyl]-oxomethyl]-4,5-dihydro-1H-pyridazin-6-one
1-[(E)-1-[4-(Difluoromethoxy)phenyl]ethylideneamino]-3-(2,6-dimethylphenyl)thiourea
C18H19F2N3OS (363.12168280000003)
N-[(E)-(5-Morpholin-4-ylthiophen-2-yl)methylideneamino]-N-phenylaniline
C21H21N3OS (363.14052560000005)
N-[[(2S)-3beta-(Ethoxycarbonyl)aziridine-2alpha-yl]carbonyl]-Gly-Gly-OBzl
C17H21N3O6 (363.14302860000004)
6-(1,3-benzodioxol-5-yl)-N-(2-oxanylmethyl)-4-quinazolinamine
1-Tetradecanoyl-sn-glycero-2,3-cyclic phosphate
C17H32O6P- (363.19364020000006)
2-[(3R,4S)-3-[[5-(methoxymethyl)-1,2-oxazol-3-yl]methyl]piperidin-4-yl]-N-(thiophen-2-ylmethyl)acetamide
hydron;1-methyl-3-(9H-thioxanthen-9-ylmethyl)piperidine;chloride;hydrate
C20H26ClNOS (363.1423536000001)
N-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-(4-morpholinyl)-2-oxoethyl]-3-oxanyl]-2-pyridinecarboxamide
3-(4-amino-1-propan-2-ylpyrazolo[3,4-d]pyrimidin-3-yl)-N-(3,4-dihydro-2H-pyrrol-5-yl)benzamide
N-[(2R,3S,6S)-2-(hydroxymethyl)-6-(2-morpholin-4-yl-2-oxoethyl)oxan-3-yl]pyridine-2-carboxamide
N-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-(4-morpholinyl)-2-oxoethyl]-3-oxanyl]-2-pyridinecarboxamide
N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-(4-morpholinyl)-2-oxoethyl]-3-oxanyl]-2-pyridinecarboxamide
4-oxanyl-[(1R,5S)-7-(4-pyridin-4-ylphenyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl]methanone
[(1-amino-2-naphthalen-1-ylethylidene)amino] N-(2-ethoxyphenyl)carbamate
N-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-(4-morpholinyl)-2-oxoethyl]-3-oxanyl]-2-pyridinecarboxamide
N-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-(4-morpholinyl)-2-oxoethyl]-3-oxanyl]-2-pyridinecarboxamide
N-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-(4-morpholinyl)-2-oxoethyl]-3-oxanyl]-2-pyridinecarboxamide
N-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-(4-morpholinyl)-2-oxoethyl]-3-oxanyl]-2-pyridinecarboxamide
(1S,5R)-N-(3-methoxyphenyl)-7-[4-[(E)-prop-1-enyl]phenyl]-3,6-diazabicyclo[3.1.1]heptane-6-carboxamide
(2R,3S,4S,5R,6S)-2-ethyl-6-{6-[(3-methylbut-2-en-1-yl)amino]-9H-purin-9-yl}oxane-3,4,5-triol
3-(4-Morpholinyl)-2-phenyl-1-[4-(trifluoromethyl)phenyl]-1-propanone
C20H20F3NO2 (363.14460560000003)
[2-[Acetyl(methyl)amino]-5-acetyloxy-1-deuterio-3,4,6-trimethoxyhexyl] acetate
Methyl (2S)-2-[1-(5-fluoropentyl)-1H-indazole-3-carboxamido]-3-methylbutanoate
E1231
E1231 is an orally active activator of Sirtuin 1 (SIRT1) (EC50=0.83 μM), to modulate cholesterol and lipid metabolism. E1231 interactes with SIRT1 (KD=9.61 μM) and deacetylated liver X receptor-alpha (LXRα), and increases ATP-binding cassette transporter A1 (ABCA1) expression. E1231 also reduces atherosclerotic plaque development in ApoE-/- mice model. E1231 can be used for research in cholesterol and lipid disorder-related diseases[1]. E1231 is an orally active activator of Sirtuin 1 (SIRT1) (EC50=0.83 μM), to modulate cholesterol and lipid metabolism. E1231 interactes with SIRT1 (KD=9.61 μM) and deacetylated liver X receptor-alpha (LXRα), and increases ATP-binding cassette transporter A1 (ABCA1) expression. E1231 also reduces atherosclerotic plaque development in ApoE-/- mice model. E1231 can be used for research in cholesterol and lipid disorder-related diseases[1].
SCD1 inhibitor-4
SCD1 inhibitor-4 is a potent, orally active stearoylCoA desaturase-1 (SCD1) inhibitor. SCD1 inhibitor-4 can be used for the research of diabetes[1].
ZINC13466751
ZINC13466751 is a potent inhibitor of HIF-1α/von Hippel-Lindau interaction with an IC50 of 2.0 μM[1].
9-hydroxy-4-methoxy-10-methyl-11-(3-methylbut-2-en-1-yl)furo[3,2-b]acridin-5-one
C22H21NO4 (363.14705060000006)
2-hydroxy-6'-(2-methylprop-1-en-1-yl)-1',7'-diazaspiro[indole-3,5'-tricyclo[7.3.0.0³,⁷]dodecan]-3'-ene-2',8'-dione
3-hydroxy-4,13b-dimethyl-1h,2h,3h,4ah,5h,6h,8h-naphtho[2,1-b]carbazole-4-carboxylic acid
C23H25NO3 (363.18343400000003)
2-amino-3-[(triphenylmethyl)sulfanyl]propanoic acid
C22H21NO2S (363.12929260000004)
(2s,4s,5s,6s)-4,5-dihydroxy-6-[3-(c-hydroxycarbonimidoylmethyl)-4-methoxyindol-1-yl]oxane-2-carboximidic acid
C17H21N3O6 (363.14302860000004)
1-[(12s)-18-acetyl-13-methyl-5,7-dioxa-13-azapentacyclo[10.7.1.0²,¹⁰.0⁴,⁸.0¹⁶,²⁰]icosa-1(19),2,4(8),9,16(20),17-hexaen-19-yl]ethanone
C22H21NO4 (363.14705060000006)
1,3-dihydroxy-2,4-bis(3-methylbut-2-en-1-yl)-10h-acridin-9-one
C23H25NO3 (363.18343400000003)
(2s)-2-amino-5-{[(1r)-1-{[(1r)-1-carboxy-2-methylpropyl]-c-hydroxycarbonimidoyl}-2-sulfanylethyl]-c-hydroxycarbonimidoyl}pentanoic acid
C14H25N3O6S (363.14639900000003)
3-benzyl-1-hydroxy-4-{4-[(3-methylbut-2-en-1-yl)oxy]phenyl}pyrrole-2,5-dione
C22H21NO4 (363.14705060000006)
(2s)-2-({hydroxy[(4s)-2-(2-hydroxyphenyl)-4,5-dihydro-1,3-oxazol-4-yl]methylidene}amino)-6-[(hydroxymethylidene)amino]hexanoic acid
C17H21N3O6 (363.14302860000004)
5-hydroxy-6-[(4-hydroxyphenyl)methyl]-3-(1h-indol-3-ylmethyl)-1-methyl-3,6-dihydropyrazin-2-one
(2s,3s,4'r)-4'-(acetyloxy)-1'-methoxy-5'-methylidene-2'-oxo-3-[(1e)-prop-1-en-1-yl]-7-oxaspiro[bicyclo[2.2.1]heptane-2,3'-pyrrolidin]-5-en-6-yl acetate
C18H21NO7 (363.13179560000003)
methyl 4-hydroxy-3-methoxy-14-(2-methoxy-2-oxoethylidene)-9-azatetracyclo[7.5.0.0¹,⁶.0¹¹,¹³]tetradec-5-ene-13-carboxylate
(1s,2r,5s,10s,13s)-10-hydroxy-1,2-dimethyl-6-oxa-22-azahexacyclo[11.10.0.0²,¹⁰.0⁵,⁹.0¹⁵,²³.0¹⁶,²¹]tricosa-8,15(23),16,18,20-pentaen-7-one
C23H25NO3 (363.18343400000003)
n-[2,5-dihydroxy-3-(2-methylpropyl)-6,7,8,9-tetrahydro-3h-1,4-diazonin-6-yl]-2,3-dihydroxybenzenecarboximidic acid
1-[(2z)-3,7-dimethylocta-2,6-dien-1-yl]-2,8-dihydroxy-9h-carbazole-3-carbaldehyde
C23H25NO3 (363.18343400000003)
1-epidechloroacutumine
{"Ingredient_id": "HBIN002511","Ingredient_name": "1-epidechloroacutumine","Alias": "NA","Ingredient_formula": "C19H25NO6","Ingredient_Smile": "CN1CCC23C1(CCC24C(C(=CC4=O)OC)O)C(=C(C(=O)C3)OC)OC","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "6885","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
1-epi-dioncophylline b
C23H25NO3 (363.18343400000003)
{"Ingredient_id": "HBIN002512","Ingredient_name": "1-epi-dioncophylline b","Alias": "NA","Ingredient_formula": "C23H25NO3","Ingredient_Smile": "CC1CC2=C(C(N1)C)C(=C(C=C2)C3=C(C4=C(C=C3)C=C(C=C4OC)C)O)O","Ingredient_weight": "363.4 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "6895","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "10498940","DrugBank_id": "NA"}
3,6,7-trimethoxyphenanthroindolizidine
C23H25NO3 (363.18343400000003)
{"Ingredient_id": "HBIN007697","Ingredient_name": "3,6,7-trimethoxyphenanthroindolizidine","Alias": "NA","Ingredient_formula": "C23H25NO3","Ingredient_Smile": "COC1CCC2N1CC(C3=C2C=CC4=C3C(=CC5=CC=CC=C45)OC)OC","Ingredient_weight": "363.4 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "21905","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "129664432","DrugBank_id": "NA"}
8-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-7-hydroxy-3-methyl-9h-carbazole-1,4-dione
C23H25NO3 (363.18343400000003)
(1s,1's,5r,6's)-5-hydroxy-2',3',4-trimethoxy-10'-methyl-10'-azaspiro[cyclopentane-1,7'-tricyclo[4.3.3.0¹,⁶]dodecane]-2',3-diene-2,4'-dione
(20s)-4,5,10-trimethoxy-16-azapentacyclo[12.7.0.0²,⁷.0⁸,¹³.0¹⁶,²⁰]henicosa-1(14),2(7),3,5,8(13),9,11-heptaene
C23H25NO3 (363.18343400000003)
(1r,5's,6'r,7'ar)-5',6,6'-trihydroxy-4,5-dimethoxy-1'-methyl-3',5',6',7'a-tetrahydro-2'h-spiro[2-benzofuran-1,7'-indol]-3-one
C18H21NO7 (363.13179560000003)
(4s,7r)-7-benzyl-6-hydroxy-4-isopropyl-15-oxa-2,5,8-triazatricyclo[8.5.0.0³,⁸]pentadeca-1(10),2,5,11,13-pentaen-9-one
methyl 14-(hydroxymethyl)-3,13,17-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-2(10),4,6,8,15(20),16,18-heptaene-19-carboxylate
{6-[cyano(phenyl)methoxy]-3,4,5-trihydroxyoxan-2-yl}methyl but-2-enoate
C18H21NO7 (363.13179560000003)
5,6,10-trimethoxy-16-azapentacyclo[12.7.0.0²,⁷.0⁸,¹³.0¹⁶,²⁰]henicosa-1(14),2(7),3,5,8(13),9,11-heptaene
C23H25NO3 (363.18343400000003)
methyl (1s,6s,7ar)-6-{[3-(4-hydroxy-3-methoxyphenyl)propanoyl]oxy}-hexahydro-1h-pyrrolizine-1-carboxylate
2-[6-(2h-1,3-benzodioxol-5-yl)hexyl]-1-methylquinolin-4-one
C23H25NO3 (363.18343400000003)
(3s,6's,9's)-2-hydroxy-6'-(2-methylprop-1-en-1-yl)-1',7'-diazaspiro[indole-3,5'-tricyclo[7.3.0.0³,⁷]dodecan]-3'-ene-2',8'-dione
8-(3,7-dimethylocta-2,6-dien-1-yl)-7-hydroxy-3-methyl-9h-carbazole-1,4-dione
C23H25NO3 (363.18343400000003)
(3r)-3-[(1r)-1-[(2s,5r)-3,6-dihydroxy-5-[(methylsulfanyl)methyl]-2,5-dihydropyrazin-2-yl]ethyl]-3-hydroxy-1-methylindol-2-one
C17H21N3O4S (363.1252706000001)
7-(1-hydroxy-8-methoxy-6-methylnaphthalen-2-yl)-1,3-dimethyl-1,2,3,4-tetrahydroisoquinolin-8-ol
C23H25NO3 (363.18343400000003)
(9's)-12',12'-dimethyl-1h-1',7'-diazaspiro[indole-2,11'-tricyclo[7.5.0.0³,⁷]tetradecane]-3',13'-diene-2',3,8'-trione
5-hydroxy-4-{[4-hydroxy-3-(3-methylbut-2-en-1-yl)phenyl]methyl}-3-(4-hydroxyphenyl)pyrrol-2-one
C22H21NO4 (363.14705060000006)
(1r,2s,6r,8s,9s,10r)-1,15-dihydroxy-9,16-dimethoxy-3-methyl-7,11-dioxa-3-azapentacyclo[8.8.0.0²,⁶.0⁶,⁸.0¹³,¹⁸]octadeca-13(18),14,16-trien-12-one
C18H21NO7 (363.13179560000003)
(20r)-5,6,10-trimethoxy-16-azapentacyclo[12.7.0.0²,⁷.0⁸,¹³.0¹⁶,²⁰]henicosa-1(14),2(7),3,5,8(13),9,11-heptaene
C23H25NO3 (363.18343400000003)
(1s,3r)-7-(5-hydroxy-4-methoxy-2-methylnaphthalen-1-yl)-1,3-dimethyl-1,2,3,4-tetrahydroisoquinolin-8-ol
C23H25NO3 (363.18343400000003)
12',12'-dimethyl-1h-1',7'-diazaspiro[indole-2,11'-tricyclo[7.5.0.0³,⁷]tetradecane]-3',13'-diene-2',3,8'-trione
7-(4-hydroxy-5-methoxy-7-methylnaphthalen-1-yl)-1,3-dimethyl-1,2,3,4-tetrahydroisoquinolin-8-ol
C23H25NO3 (363.18343400000003)
(1r,3r)-7-(4-hydroxy-5-methoxy-7-methylnaphthalen-1-yl)-1,3-dimethyl-1,2,3,4-tetrahydroisoquinolin-8-ol
C23H25NO3 (363.18343400000003)
4,5,10-trimethoxy-16-azapentacyclo[12.7.0.0²,⁷.0⁸,¹³.0¹⁶,²⁰]henicosa-1(14),2(7),3,5,8(13),9,11-heptaene
C23H25NO3 (363.18343400000003)
(20r)-4,5,10-trimethoxy-16-azapentacyclo[12.7.0.0²,⁷.0⁸,¹³.0¹⁶,²⁰]henicosa-1(14),2(7),3,5,8(13),9,11-heptaene
C23H25NO3 (363.18343400000003)
n-{2-[5-(4-hydroxyphenyl)-4,8-dioxo-1h,7h-pyrrolo[3,2-f]indol-3-yl]ethyl}-n-methylformamide
7-(5-hydroxy-4-methoxy-2-methylnaphthalen-1-yl)-1,3-dimethyl-1,2,3,4-tetrahydroisoquinolin-8-ol
C23H25NO3 (363.18343400000003)
(8s,11r,12s)-4,11-dimethoxy-17-methyl-18-oxa-17-azapentacyclo[8.4.3.1⁸,¹¹.0¹,¹⁰.0²,⁷]octadeca-2,4,6-triene-3,12,13-triol
(3r)-7-(1-hydroxy-8-methoxy-6-methylnaphthalen-2-yl)-1,3-dimethyl-1,2,3,4-tetrahydroisoquinolin-8-ol
C23H25NO3 (363.18343400000003)
(2s)-18-methoxy-21-oxa-6,14,23-triazapentacyclo[12.9.0.0²,⁶.0⁸,¹³.0¹⁶,²²]tricosa-1(23),8,10,12,16(22),17,19-heptaene-7,15-dione
5-{[(1r)-1-amino-1-{[(1s)-1-carboxy-2-methylpropyl]-c-hydroxycarbonimidoyl}-2-sulfanylethyl]-c-hydroxycarbonimidoyl}pentanoic acid
C14H25N3O6S (363.14639900000003)
2-({hydroxy[2-(2-hydroxyphenyl)-4,5-dihydro-1,3-oxazol-4-yl]methylidene}amino)-6-[(hydroxymethylidene)amino]hexanoic acid
C17H21N3O6 (363.14302860000004)
(1r,2s,13r,15s)-15-hydroxy-1,2-dimethyl-16-oxa-4-azahexacyclo[13.6.1.0²,¹³.0³,¹¹.0⁵,¹⁰.0¹⁸,²²]docosa-3(11),5,7,9,18(22)-pentaene-17,19-dione
C22H21NO4 (363.14705060000006)
methyl 6-{[3-(4-hydroxy-3-methoxyphenyl)propanoyl]oxy}-hexahydro-1h-pyrrolizine-1-carboxylate
methyl (1s,3r,4s,11s,13s,14e)-4-hydroxy-3-methoxy-14-(2-methoxy-2-oxoethylidene)-9-azatetracyclo[7.5.0.0¹,⁶.0¹¹,¹³]tetradec-5-ene-13-carboxylate
(2s,9's)-12',12'-dimethyl-1h-1',7'-diazaspiro[indole-2,11'-tricyclo[7.5.0.0³,⁷]tetradecane]-3',13'-diene-2',3,8'-trione
(1s,8s,10s,11r,12s,13s)-4,11,12-trimethoxy-18-oxa-17-azapentacyclo[8.4.3.1⁸,¹¹.0¹,¹⁰.0²,⁷]octadeca-2,4,6-triene-3,13-diol
1-(3,7-dimethylocta-2,6-dien-1-yl)-2,8-dihydroxy-9h-carbazole-3-carbaldehyde
C23H25NO3 (363.18343400000003)
6,7-dimethoxy-4-(4-methoxyphenyl)-1-methyl-3h-naphtho[2,3-d]imidazol-2-imine
4'-(acetyloxy)-1'-methoxy-5'-methylidene-2'-oxo-3-(prop-1-en-1-yl)-7-oxaspiro[bicyclo[2.2.1]heptane-2,3'-pyrrolidin]-5-en-6-yl acetate
C18H21NO7 (363.13179560000003)
12-methoxy-17-[(2s)-pyrrolidin-2-yl]-9-oxa-1,16-diazatetracyclo[8.7.1.0²,⁷.0¹⁴,¹⁸]octadeca-2,4,6,10(18),11,13,16-heptaene-8,15-dione
(2s)-20-hydroxy-18-methoxy-6,14,22-triazapentacyclo[12.8.0.0²,⁶.0⁸,¹³.0¹⁶,²¹]docosa-1(22),8,10,12,16,18,20-heptaene-7,15-dione
(1r,1's,5r,6's)-5-hydroxy-2',3',4-trimethoxy-10'-methyl-10'-azaspiro[cyclopentane-1,7'-tricyclo[4.3.3.0¹,⁶]dodecane]-2',3-diene-2,4'-dione
(1r,3s)-5-(5-hydroxy-4-methoxy-2-methylnaphthalen-1-yl)-1,3-dimethyl-1,2,3,4-tetrahydroisoquinolin-8-ol
C23H25NO3 (363.18343400000003)
18-methoxy-21-oxa-6,14,23-triazapentacyclo[12.9.0.0²,⁶.0⁸,¹³.0¹⁶,²²]tricosa-1(23),8,10,12,16(22),17,19-heptaene-7,15-dione
(3s,4s,4ar,13bs)-3-hydroxy-4,13b-dimethyl-1h,2h,3h,4ah,5h,6h,8h-naphtho[2,1-b]carbazole-4-carboxylic acid
C23H25NO3 (363.18343400000003)
(20s)-5,10,11-trimethoxy-16-azapentacyclo[12.7.0.0²,⁷.0⁸,¹³.0¹⁶,²⁰]henicosa-1(14),2(7),3,5,8(13),9,11-heptaene
C23H25NO3 (363.18343400000003)
n-(2-{2-[1-(dimethylamino)-2-phenylethyl]-1,3-oxazole-5-carbonyl}phenyl)carboximidic acid
(21s)-5,11-dimethoxy-16-azapentacyclo[12.8.0.0²,⁷.0⁸,¹³.0¹⁶,²¹]docosa-1(14),2(7),3,5,8(13),9,11-heptaen-10-ol
C23H25NO3 (363.18343400000003)
20-hydroxy-18-methoxy-6,14,22-triazapentacyclo[12.8.0.0²,⁶.0⁸,¹³.0¹⁶,²¹]docosa-1(22),8,10,12,16,18,20-heptaene-7,15-dione
2-[6-(2h-1,3-benzodioxol-5-yl)hexyl]-4-methoxyquinoline
C23H25NO3 (363.18343400000003)
7-benzyl-6-hydroxy-4-isopropyl-15-oxa-2,5,8-triazatricyclo[8.5.0.0³,⁸]pentadeca-1(10),2,5,11,13-pentaen-9-one
(1s,1's,5s,6's)-5-hydroxy-2',3',4-trimethoxy-10'-methyl-10'-azaspiro[cyclopentane-1,7'-tricyclo[4.3.3.0¹,⁶]dodecane]-2',3-diene-2,4'-dione
(3s,6s)-3-(1-hydroxyethyl)-6-(1h-indol-3-ylmethyl)-6-methoxy-3-(methylsulfanyl)pyrazine-2,5-diol
C17H21N3O4S (363.1252706000001)
1,15-dihydroxy-9,16-dimethoxy-3-methyl-7,11-dioxa-3-azapentacyclo[8.8.0.0²,⁶.0⁶,⁸.0¹³,¹⁸]octadeca-13(18),14,16-trien-12-one
C18H21NO7 (363.13179560000003)
(1r,9s,10r,11r,12s)-13-[(2z)-3-methoxy-4-methyl-5-oxofuran-2-ylidene]-12-methyl-14,15-dioxa-5-azatetracyclo[7.5.1.0¹,¹¹.0⁵,¹⁰]pentadecan-5-ium-5-olate
methyl (1r,6r,7ar)-6-{[3-(4-hydroxy-3-methoxyphenyl)propanoyl]oxy}-hexahydro-1h-pyrrolizine-1-carboxylate
(3s,6s)-5-hydroxy-6-[(4-hydroxyphenyl)methyl]-3-(1h-indol-3-ylmethyl)-1-methyl-3,6-dihydropyrazin-2-one
methyl (1r,6s,7ar)-6-{[3-(4-hydroxy-3-methoxyphenyl)propanoyl]oxy}-hexahydro-1h-pyrrolizine-1-carboxylate
7-(1-hydroxy-8-methoxy-3-methylnaphthalen-2-yl)-1,3-dimethyl-1,2,3,4-tetrahydroisoquinolin-8-ol
C23H25NO3 (363.18343400000003)
[(2r,3s,4s,5r,6r)-6-[(r)-cyano(phenyl)methoxy]-3,4,5-trihydroxyoxan-2-yl]methyl (2e)-but-2-enoate
C18H21NO7 (363.13179560000003)
(3s)-3-[(1r)-1-[(2s,5r)-3,6-dihydroxy-5-[(methylsulfanyl)methyl]-2,5-dihydropyrazin-2-yl]ethyl]-3-hydroxy-1-methylindol-2-one
C17H21N3O4S (363.1252706000001)
(1r,4z,7r)-4-ethylidene-7-hydroxy-7,14-dimethyl-6-methylidene-2,9-dioxa-14-azabicyclo[9.5.1]heptadec-11-ene-3,8,17-trione
5-hydroxy-2',3',4-trimethoxy-10'-methyl-10'-azaspiro[cyclopentane-1,7'-tricyclo[4.3.3.0¹,⁶]dodecane]-2',3-diene-2,4'-dione
(1r,3r)-7-(1-hydroxy-8-methoxy-3-methylnaphthalen-2-yl)-1,3-dimethyl-1,2,3,4-tetrahydroisoquinolin-8-ol
C23H25NO3 (363.18343400000003)
(2s)-2-[(2-amino-1-hydroxy-3-{[(2e)-1-hydroxy-4-methoxy-4-oxobut-2-en-1-ylidene]amino}propylidene)amino]-3-phenylpropanoic acid
C17H21N3O6 (363.14302860000004)
(1r,2r,4s,5r,7r,12r,15s,23r)-4-amino-18-methoxy-6-oxa-8,16-diazaoctacyclo[10.10.1.0¹,¹⁵.0²,⁷.0⁴,¹⁵.0⁵,¹².0⁸,²³.0¹⁷,²²]tricosa-10,17(22),18,20-tetraen-3-one
(1r,1's,5s,6's)-5-hydroxy-2',3',4-trimethoxy-10'-methyl-10'-azaspiro[cyclopentane-1,7'-tricyclo[4.3.3.0¹,⁶]dodecane]-2',3-diene-2,4'-dione
(1r,3r)-7-(5-hydroxy-4-methoxy-2-methylnaphthalen-1-yl)-1,3-dimethyl-1,2,3,4-tetrahydroisoquinolin-8-ol
C23H25NO3 (363.18343400000003)